Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 87

1.

Biokinetics of yttrium-90--labeled huBrE-3 monoclonal antibody.

Johnson TK, Cole W, Quaife RA, Lear JL, Ceriani RL, Jones RB, Cagnoni PJ.

Cancer. 2002 Feb 15;94(4 Suppl):1240-8.

2.

Structural and functional aspects of three major glycoproteins of the human milk fat globule membrane.

Peterson JA, Scallan CD, Ceriani RL, Hamosh M.

Adv Exp Med Biol. 2001;501:179-87. Review.

PMID:
11787681
3.

Protective function of human milk: the milk fat globule.

Hamosh M, Peterson JA, Henderson TR, Scallan CD, Kiwan R, Ceriani RL, Armand M, Mehta NR, Hamosh P.

Semin Perinatol. 1999 Jun;23(3):242-9. Review.

PMID:
10405194
4.

Construction and characterization of a chimeric fusion protein consisting of an anti-idiotype antibody mimicking a breast cancer-associated antigen and the cytokine GM-CSF.

Tripathi PK, Qin H, Bhattacharya-Chatterjee M, Ceriani RL, Foon KA, Chatterjee SK.

Hybridoma. 1999 Apr;18(2):193-202.

PMID:
10380019
5.

Milk fat globule glycoproteins in human milk and in gastric aspirates of mother's milk-fed preterm infants.

Peterson JA, Hamosh M, Scallan CD, Ceriani RL, Henderson TR, Mehta NR, Armand M, Hamosh P.

Pediatr Res. 1998 Oct;44(4):499-506.

PMID:
9773837
6.

Initial clinical evaluation of radiolabeled MX-DTPA humanized BrE-3 antibody in patients with advanced breast cancer.

Kramer EL, Liebes L, Wasserheit C, Noz ME, Blank EW, Zabalegui A, Melamed J, Furmanski P, Peterson JA, Ceriani RL.

Clin Cancer Res. 1998 Jul;4(7):1679-88.

7.

Role of human-milk lactadherin in protection against symptomatic rotavirus infection.

Newburg DS, Peterson JA, Ruiz-Palacios GM, Matson DO, Morrow AL, Shults J, Guerrero ML, Chaturvedi P, Newburg SO, Scallan CD, Taylor MR, Ceriani RL, Pickering LK.

Lancet. 1998 Apr 18;351(9110):1160-4.

PMID:
9643686
8.

Conjugation of interferon alpha to a humanized monoclonal antibody (HuBrE-3vl) enhances the selective localization and antitumor effects of interferon in breast cancer xenografts.

Ozzello L, Blank EW, De Rosa CM, Ceriani RL, Tölö H, Kauppinen HL, Cantell K.

Breast Cancer Res Treat. 1998 Mar;48(2):135-47.

PMID:
9596485
9.

Radioimmunotherapy for breast cancer using indium-111/yttrium-90 BrE-3: results of a phase I clinical trial.

DeNardo SJ, Kramer EL, O'Donnell RT, Richman CM, Salako QA, Shen S, Noz M, Glenn SD, Ceriani RL, DeNardo GL.

J Nucl Med. 1997 Aug;38(8):1180-5.

10.
11.
12.

Inverted Fab2s (IFab2s): engineering and expression of novel, dimeric molecules, with a molecular weight of 100 000.

Speck RR, Couto JR, Godwin SG, Christian RB, Kiwan R, Ceriani RL, Peterson JA.

Mol Immunol. 1996 Oct;33(14):1095-102.

PMID:
9047375
13.

Cloning and sequence analysis of human butyrophilin reveals a potential receptor function.

Taylor MR, Peterson JA, Ceriani RL, Couto JR.

Biochim Biophys Acta. 1996 Apr 10;1306(1):1-4.

PMID:
8611614
14.

Cloning and expression of cDNAs encoding the variable domains of the antibreast carcinoma antibody Mc5.

Christian RB, Couto JR, Peterson JA, Ceriani RL.

Hybridoma. 1996 Apr;15(2):155-8.

PMID:
8743296
15.
16.

Designing human consensus antibodies with minimal positional templates.

Couto JR, Christian RB, Peterson JA, Ceriani RL.

Cancer Res. 1995 Dec 1;55(23 Suppl):5973s-5977s.

17.
18.

Selection of tumor-specific epitopes on target antigens for radioimmunotherapy of breast cancer.

Peterson JA, Couto JR, Taylor MR, Ceriani RL.

Cancer Res. 1995 Dec 1;55(23 Suppl):5847s-5851s.

19.
20.

Induction of human breast cancer-specific antibody responses in cynomolgus monkeys by a murine monoclonal anti-idiotype antibody.

Chakraborty M, Mukerjee S, Foon KA, Köhler H, Ceriani RL, Bhattacharya-Chatterjee M.

Cancer Res. 1995 Apr 1;55(7):1525-30.

21.

Humanization of KC4G3, an anti-human carcinoma antibody.

Couto JR, Padlan EA, Blank EW, Peterson JA, Ceriani RL.

Hybridoma. 1994 Jun;13(3):215-9.

PMID:
7927365
22.

Engineering of antibodies for breast cancer therapy: construction of chimeric and humanized versions of the murine monoclonal antibody BrE-3.

Couto JR, Blank EW, Peterson JA, Kiwan R, Padlan EA, Ceriani RL.

Adv Exp Med Biol. 1994;353:55-9. No abstract available.

PMID:
7985542
23.

Experimental immunotherapy of breast cancer using alpha interferon conjugated to monoclonal antibody Mc5.

Ozzello L, De Rosa CM, Blank EW, Cantell K, Ceriani RL, Habif DV Sr.

Adv Exp Med Biol. 1994;353:35-46. No abstract available.

PMID:
7985540
24.

Multivariate prognostic model for infiltrating ductal carcinoma of the breast in the axillary node-free patient.

Ceriani RL, Baratta F, Gaslonde RJ, De Rosa CM, Ozzello L.

Adv Exp Med Biol. 1994;353:155-67. No abstract available.

PMID:
7985534
25.

Anti-idiotype antibodies as potential therapeutic agents for human breast cancer.

Bhattacharya-Chatterjee M, Mrozek E, Mukerjee S, Ceriani RL, Kohler H, Foon KA.

Adv Exp Med Biol. 1994;353:139-48. No abstract available.

PMID:
7985532
26.

Monoclonal antibody BrE-3 participation in a multivariate prognostic model for infiltrating ductal carcinoma of the breast.

Chan CM, Baratta FS, Ozzello L, Ceriani RL.

Breast Cancer Res Treat. 1994;30(3):243-61.

PMID:
7981443
27.

Breast mucin and associated antigens in diagnosis and therapy.

Peterson JA, Ceriani RL.

Adv Exp Med Biol. 1994;353:1-8. Review. No abstract available.

PMID:
7527177
28.

Cloning of cDNAs encoding the variable domains of antibody KC4G3 and construction of a chimeric antibody.

Couto JR, Blank EW, Peterson JA, Ceriani RL.

Hybridoma. 1993 Aug;12(4):485-9.

PMID:
8244420
29.

Cloning of cDNAs encoding the variable domains of antibody BrE-3 and construction of a chimeric antibody.

Couto JR, Blank EW, Peterson JA, Ceriani RL.

Hybridoma. 1993 Feb;12(1):15-23.

PMID:
8454302
30.

The use of natural interferon alpha conjugated to a monoclonal antibody anti mammary epithelial mucin (Mc5) for the treatment of human breast cancer xenografts.

Ozzello L, De Rosa CM, Blank EW, Cantell K, Ceriani RL, Habif DV Sr.

Breast Cancer Res Treat. 1993;25(3):265-76.

PMID:
8369527
31.

Epitope expression on the breast epithelial mucin.

Ceriani RL, Peterson JA, Blank EW, Lamport DT.

Breast Cancer Res Treat. 1992;24(2):103-13.

PMID:
7680246
32.

5-Iododeoxyuridine increases the efficacy of the radioimmunotherapy of human tumors growing in nude mice.

Santos O, Pant KD, Blank EW, Ceriani RL.

J Nucl Med. 1992 Aug;33(8):1530-4.

33.

Development and characterization of breast carcinoma cell lines as in vitro and in vivo models for breast cancer diagnosis and therapy.

Ceriani RL, Peterson JA, Blank EW, Chan CM, Cailleau R.

In Vitro Cell Dev Biol. 1992 Jun;28A(6):397-402.

PMID:
1634439
34.

Levels of expression of breast epithelial mucin detected by monoclonal antibody BrE-3 in breast-cancer prognosis.

Ceriani RL, Chan CM, Baratta FS, Ozzello L, DeRosa CM, Habif DV.

Int J Cancer. 1992 May 28;51(3):343-54.

PMID:
1592525
36.

A novel serum assay for breast epithelial antigen using a fusion protein.

Ceriani RL, Larocca D, Peterson JA, Enloe S, Amiya R, Walkup G, Blank EW.

Anal Biochem. 1992 Feb 14;201(1):178-84.

PMID:
1377884
37.

Distribution of a breast-directed I-131-radiolabeled monoclonal antibody in blood and bone marrow: implications for radiation immunotherapy.

Johnson TK, Gonzalez R, Kasliwal RK, Lear JL, Feyerabend AJ, Dienhart DG, Ceriani RL, Bunn PA Jr.

Radiology. 1992 Jan;182(1):107-14.

PMID:
1727271
38.

Effect of human mammary MX-1 tumor on plasma free fatty acids in fasted and fasted-refed nude mice.

Lin C, Blank W, Ceriani RL, Baker N.

Lipids. 1992 Jan;27(1):33-7.

PMID:
1608300
39.

Detection of minimal residual breast cancer in bone marrow.

Johnston CS, Shpall EJ, Williams S, Hami L, Jones RB, Bast RC, Ceriani RL, Franklin W.

Prog Clin Biol Res. 1992;377:637-42. No abstract available.

PMID:
1438446
40.

A Mr 46,000 human milk fat globule protein that is highly expressed in human breast tumors contains factor VIII-like domains.

Larocca D, Peterson JA, Urrea R, Kuniyoshi J, Bistrain AM, Ceriani RL.

Cancer Res. 1991 Sep 15;51(18):4994-8.

42.

Breast epithelial mucin serum clearance.

Ceriani RL, Blank EW.

Cancer Lett. 1991 Jun 14;58(1-2):65-8.

PMID:
2049783
43.

Breast epithelial antigen levels and breast tumor antigen content.

Ceriani RL, Chan C.

Breast Cancer Res Treat. 1990 Nov;17(1):55-8.

PMID:
2095928
44.

Cloning and sequencing of a complementary DNA encoding a Mr 70,000 human breast epithelial mucin-associated antigen.

Larocca D, Peterson JA, Walkup G, Urrea R, Ceriani RL.

Cancer Res. 1990 Sep 15;50(18):5925-30.

45.
47.

Diagnostic ability of different human milk fat globule antigens in breast cancer.

Ceriani RL, Blank EW, Rosenbaum EH, Ben Zeev D, Lowitz RS, Johansen L, Trujillo T.

Breast Cancer Res Treat. 1990 May;15(3):161-74.

PMID:
2372570
48.

Breast epithelial antigens in the circulation of breast cancer patients.

Ceriani RL, Rosenbaum EH.

Immunol Ser. 1990;53:223-41. Review. No abstract available.

PMID:
2100557
49.

Human milk-fat globule membrane derived mucin is a disulfide-linked heteromer.

Duwe AK, Ceriani RL.

Biochem Biophys Res Commun. 1989 Dec 29;165(3):1305-11.

PMID:
2692565
50.

Supplemental Content

Loading ...
Support Center